The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies: Evidence and clinical judgment

Thrombosis and Haemostasis

Volumn 115, Issue 2, 2016, Pages 285-290

  Sciascia, Savino ^a,b   Branch, D Ware ^c   Levy, Roger A ^d   Middeldorp, Saskia ^e   Pavord, Sue ^f,g   Roccatello, Dario ^b   Ruiz Irastorza, Guillermo ^h   Tincani, Angela ⁱ   Khamashta, Munther ^a   Schreiber, Karen ^a,j   Hunt, Beverley J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b S GIOVANNI BOSCO HOSPITAL   (Italy)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^g OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^h BIOCRUCES BIZKAIA HEALTH RESEARCH INSTITUTE   (Spain)

ⁱ UNIVERSITY OF BRESCIA   (Italy)

^j Mental Health Services CPH   (Denmark)

more..

Author keywords

Antiphospholipid antibodies; Antiphospholipid syndrome; Pregnancy

Indexed keywords

HYDROXYCHLOROQUINE; PHOSPHOLIPID ANTIBODY; ACETYLSALICYLIC ACID; HEPARIN;

ARTICLE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; HUMAN; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; QUESTIONNAIRE; SYSTEMIC LUPUS ERYTHEMATOSUS; ANTIPHOSPHOLIPID SYNDROME; BLOOD; COHORT ANALYSIS; COMPLICATION; FEMALE; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; OBSTETRICS; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PROSPECTIVE STUDY; STANDARDS; THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; COHORT STUDIES; FEMALE; HEPARIN; HUMANS; HYDROXYCHLOROQUINE; LUPUS ERYTHEMATOSUS, SYSTEMIC; OBSTETRICS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; THROMBOSIS;

EID: 84957565813     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH15-06-0491     Document Type: Article

References (17)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295–306.
2. Ruiz-Irastorza G, Crowther M, Branch W, et al. Antiphospholipid syndrome. Lancet 2010; 376: 1498–1509.
3. Bramham K, Thomas M, Nelson-Piercy C, et al. First-trimester low- dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. Blood 2011; 117: 6948–6951.
4. Mekinian A, Costedoat-Chalumeau N, Masseau A, et al. Obstetrical APS: Is there a place for hydroxychloroquine to improve the pregnancy outcome?, Autoimmun Rev 2015; 14: 23–29.
5. Mekinian A, Lazzaroni MG, Kuzenko A, et al. The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study. Autoimmun Rev 2015; 14: 498–502.
6. Ruiz-Irastorza G, Egurbide MV, Pijoan JI, et al. Effect of antimalarials on thrombosis and survival in patients with systemic 645 lupus erythematosus. Lupus 2006; 15: 577–583.
7. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, et al. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010; 69: 20–28.
8. Shinjo SK, Bonfa E, Wojdyla D, et al. Antimalarial treatment may have a timedependent effect on lupus survival: data from a multinational Latin American inception cohort. Arthritis Rheum 2010; 62: 855–862.
9. Jancinova V, Nosal R, Petrikova M. On the inhibitory effect of chloroquine on blood platelet aggregation. Thromb Res 1994;. 74: 495–504.
10. Pierangeli SS, Vega-Ostertag M, Harris EN. Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies. Thromb Res 2004; 114: 467–476.
11. Rand JH, Wu XX, Quinn AS, et al., Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers. Blood 2008; 112: 1687–1695.
12. Ageno W, Dentali F, Squizzato A, et al, Evidence and clinical judgment: Treatment of cerebral vein thrombosis. Thromb Haemost 2010; 103: 1109–1115.
13. Kappa as a Measure of Concordance in Categorical Sorting. Available at: http://facultyvassaredu/lowry/kappahtml. Accessed May 28, 2014.
14. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheuma 1999; 42:1309–1311.
15. Buchanan NM, Toubi E, Khamashta M, et al. Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases Ann Rheum Dis 1996; 55: 486–488.
16. Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann Rheum Dis 2010; 69: 20–28.
17. van Tulder M, Furlan A, Bombardier C, et al.; Editorial Board of the Cochrane Collaboration Back Review Group. Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine 2003; 28: 1290–1299.